Ownership history in Nemes Rush Group LLC Β· 11 quarters on record
This page tracks every 13F SEC filing in which Nemes Rush Group LLC reported a position in CME GROUP INC (CME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Nemes Rush Group LLC outperformed the S&P 500 by +1.3% annually on this CME position. Timing score: 70% (7/10 decisions correct). Average cost basis: $173.34. Maximum drawdown during holding period: β8.2%.
β
Outperformed SPY on this position by 1.3% ann.
10 quarters analyzed
π― Smart timing β consistently buying dips and trimming near peaks.
7 of 10 add/trim decisions correct
Best entry: $163.79 (2023 Q2) Β· Worst: $266.67 (2025 Q2)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
9 adds Β· 2 trims. Bought during 2 of 2 down-price quarters. π Consistently bullish β fund kept accumulating this position.
π Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 1.73% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size